AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jul 7, 2022
50715_rns_2022-07-07_f64661d4-7e09-486d-9bb9-05a151c9d62a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
7 July 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Description | Nature of dealings | Purchase / | Total | Total amount | Highest (H) | Lowest (L) |
|---|---|---|---|---|---|---|---|---|
| of relevant | Sale | number | paid / received | prices paid | prices paid | |||
| securities | of shares | / received | / received | |||||
| involved | ||||||||
| China | 6 July 2022 | Other types | Closing / flattening / unwinding of | Sale | 8,000 | $158,640.0000 | $19.8300 | $19.8300 |
| International | of securities | proprietary positions arising from | ||||||
| Capital | (e.g. equity | unsolicited client-driven dealings. I | ||||||
| Corporation | swaps) | confirm this was done no later than the | ||||||
| Limited | close of the morning trading session | |||||||
| on the trading day following the | ||||||||
| orginatingclient-driven dealing |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
| Other typesof securities(e.g. equityswaps) | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading sessionon the trading day following theorginatingclient-driven dealing | Purchase | 8,000 | $158,640.0000 | $19.8300 | $19.8300 |
|---|
End
Note:
China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20